ORBI Risk Score
Development of in-hospital cardiogenic shock prediction in patients
with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
The ORBI Risk Score has been developed by The ORBI and RICO investigators.
It is designed to assist prediction of development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
It should not be considered a substitute for clinical assessment.

Variables

Age > 70 years old
Anterior Myocardial Infarction
Hearth rate > 90/min on admission
Glycaemia > 10 mmol/l on admission
Post-pPCI TIMI flow < 3
Culprit lesion of the left main
Previous Stroke / TIA
Presentation as Cardiac Arrest
Killip Class on admission
First medical contact-to-pPCI delay > 90min
Systolic & Diastolic Blood Pressure on admission

Abbreviations

CS Cardiogenic Shock
DBP Diastolic Blood Pressure
ORBI Observatoire Régional Breton sur l'Infarctus du myocarde
pPCI Primary percutaneous coronary intervention
RICO obseRvatoire des Infarctus de Côte-d'Or
SBP Systolic Blood Pressure
TIA Transient ischemic attack
TIMI Thrombolysis In Myocardial Infarction

Reference

Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.

Auffret V, Cottin Y, Leurent G, Gilard M, Beer JC, Zabalawi A, Chagué F, Filippi E, Brunet D, Hacot JP, Brunel P, Mejri M, Lorgis L, Rouault G, Druelles P, Cornily JC, Didier R, Bot E, Boulanger B, Coudert I, Loirat A, Bedossa M, Boulmier D, Maza M, Le Guellec M, Puri R, Zeller M, Le Breton H; ORBI and RICO Working Groups.

Eur Heart J 2018;39:2090–2102

Risk Categories

Category Score Observed incidence of CS in the derivation cohort (%)
Low 0 - 7 1.3
Low-to-Intermediate 8 - 10 6.6
Intermediate-to-High 11 / 12 11.7
High 13 + 31.8